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We evaluated the use of hyperpolarized 13C magnetic resonance imaging (MRI) in an open-chest rat model
of myocardial infarction to image regional changes in myocardial metabolism. In total, 10 rats were exam-
ined before and after 30 minutes of occlusion of the left anterior descending coronary artery using hyperpo-
larized [1-13C]pyruvate. Cardiac metabolic images of [1-13C]pyruvate and its metabolites [1-13C]lactate,
[1-13C]alanine, and [13C]bicarbonate were obtained before and after ischemia. Significant reduction in the
[1-13C]alanine and [1-13C]lactate signals were observed in the ischemic region post ischemia. The severity
of the ischemic insult was verified by increased blood levels of troponin I and by using late contrast-en-
hanced MRI that showed enhanced signal in the ischemic region. This study shows that hyperpolarized MRI
can be used to image regional metabolic changes in the in vivo rat heart in an open-chest model of isch-
emia reperfusion. Hyperpolarized MRI enables new possibilities for evaluating changes in cardiac metabo-
lism noninvasively and in real time, which potentially could be used for research to evaluate new treatments
and metabolic interventions for myocardial ischemia and to apply knowledge to future application of the
technique in humans.
INTRODUCTION
Changes in myocardial metabolism are known to be one of the
earliest markers of ischemic heart disease (1). Rodent animal
models offer unique opportunities to study these changes. How-
ever, imaging the rat heart in vivo offers several challenges. In
comparison to humans or pigs, the rat heart is much smaller
(20 mm in length) with a relatively thinner myocardium, and
furthermore, it beats 5–6 times faster (up to 450 bpm). Despite
this, some of the most used and best characterized models of
cardiac diseases are developed in rats.
Hyperpolarized [1-13C]pyruvate magnetic resonance imag-
ing (MRI), an emerging imaging technique, can assess and vi-
sualize regional metabolic changes in intact beating heart in real
time (2-7). The advantage of hyperpolarization is that the mag-
netic resonance spectroscopy signal from 13C-labeled metabo-
lites can be increased 10,000-fold (8), making it possible to
detect low concentrations of the metabolites in vivo and to
create metabolic images of the signal. Moreover, hyperpolarized
MRI enables monitoring of several steps in metabolic pathways,
adding information of fluxes through specific enzymes in the
cardiac myocytes cytosol and mitochondria. It can further easily
be used in combination with conventional proton MRI to assess
cardiac anatomy, function, perfusion, and viability with gado-
linium (Gd)-based contrast agents.
In this study, hyperpolarized [1-13C]pyruvate was used. Py-
ruvate is the end product of glycolysis and a key substrate for
energy production through tricarboxylic acid cycle. After intra-
venous injection, hyperpolarized [1-13C]pyruvate is taken up by
the myocytes and converted into [1-13C]lactate via the enzyme
lactate dehydrogenase and [1-13C]alanine via alanine amino-
transferase, both enzymes located in the cytosol. Furthermore,
[1-13C]pyruvate is converted into acetyl coenzyme A via the
pyruvate dehydrogenase enzyme complex in the mitochondrial
membrane, and in the process, the 13C-atom in the C-1 position
of the pyruvate molecule is transferred to (13) CO2 in equilib-
rium with the large bicarbonate pool via the enzyme carbonic
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anhydrase. The production of [13C]bicarbonate reflects the mi-
tochondrial status, whereas the production of [1-13C]lactate and
[1-13C]alanine reflects the general metabolic state of the myo-
cytes, according to the location and activity of the enzymes in
the cell. The metabolic consequences of myocardial ischemia
have previously been shown in animal models, primarily in
isolated perfused rat hearts (2, 7, 9) or in pigs (3, 6, 10). Recently,
the technique has been applied in the in vivo rat heart in a
complicated closed survival model of acute myocardial ischemia
(11). In the present paper, we show an alternative approach to
image the metabolic effects of regional myocardial ischemia in
the in vivo rat heart, and demonstrate how challenges connected
with its use in the small rapidly beating heart can be circum-
vented.
METHODS
Animals
All experiments were approved by The Danish Animal Experi-
ments Inspectorate (License number: 2007/561-1350). In total,
12 male Sprague–Dawley rats (Taconic Europe, Denmark)
weighing 250–350 g were examined in this study; 10 were
examined with conventional MRI and hyperpolarized [1-13C]py-
ruvate before and 2 hours after ischemia. The remaining 2 rats
were sham-operated and used only for evaluation of troponin I
blood levels. All rats were given water and standard rat chow ad
libitum. The preischemic scan was performed 1 or 2 days before
the ischemic insult was performed to reduce the time the rats
were anesthetized, which potentially could affect our results.
The preischemic scan was performed as described below but
without the surgery. Rats were anesthetized with 4% isoflurane.
The rats were intubated and connected to a small animal venti-
lator (SAR-830/P, IITC Life Science, CA). The ventilator was
supplied with 1.75 L/min atmospheric air with additional 0.25
L/min oxygen mixed with 1.6%–2% isoflurane to maintain light
anesthesia. Respiration was kept at 72 breaths/min. pCO2 was
monitored on a NPB-75MAX Capnograph (Nellcor Puritan Ben-
nett Inc, USA) connected to the ventilator. A catheter was
introduced into the tail vein for intravenous administration of
the hyperpolarized [1-13C]pyruvate solution. Another catheter
was introduced in the left femoral artery for blood collection.
During scanning, the animals were placed on a heating pad, and
temperature, electrocardiogram (ECG), and expiration gases
were monitored (body temperature: 37.0–38.0°C, expiration
CO2: 3.5–4.0 kPa).
Ischemic Heart Model
Myocardial ischemia was induced by a previously described
open-chest technique (12, 13). The rats were anesthetized, intu-
bated, and connected to a small animal ventilator as described
above. For additional pain relief, 0.05 g/g buprenorphine
(Temgesic, Reckitt Benckiser, Søborg, Denmark) was given sub-
cutaneously 15–30 minutes before surgery. After a left thora-
cotomy and a pericardiectomy, the left anterior descending
(LAD) artery was occluded by placing a ligature around a little
plastic tube placed on top of the branch. Ischemia was verified
visually by bleaching and blue-coloring of the myocardium
distal to the ligature. The ligature was placed to achieve an
ischemic area covering 1/2 of the anterior wall of the left
ventricle including the apex. The LAD coronary artery was
occluded for 30 minutes, resulting in severe ischemia and in-
farction. Ischemia was followed by reperfusion achieved by
releasing the tension of the ligature. A clear change in color
from blue to red confirmed reperfusion. If reperfusion was not
achieved, the rats were excluded from the study. For evaluation
of tissue damage by the cardiac-specific biomarker troponin I,
blood samples were drawn before ischemia and 1 and 2 hours
after reperfusion in 6 of the 10 ischemic rats (owing to problems
with the blood clotting in the catheter in the remaining 4). The
level of troponin I was analyzed on an AQT90 Flex (Radiometer,
Denmark). The 2 sham-operated animals underwent the surgical
procedure including placing the ligature, but without occluding
the artery.
Hyperpolarization
Here, 20 L (26 mg) of [1-13C]pyruvic acid (Sigma Aldrich,
Germany) with 15mM trityl radical OX063 (Oxford Instruments,
UK) and 1.5mM Dotarem (Guerbet, France) was loaded into a
polarizer (HyperSense, Oxford Instruments, UK). The sample was
dissolved in a neutralizing buffer (80 mM TRIS, 100 mg/L EDTA,
50 mM NaCl, 80mM NaOH), achieving a final concentration of
80 mM [1-13C]pyruvate (pH 7.0–8.0, temperature 30°C, iso-
tonic).
MRI
A 4.7 T preclinical MRI and magnetic resonance spectroscopy
system (Agilent, Santa Clara, CA) at the Danish Research Centre
for Magnetic Resonance was used for the magnetic resonance
(MR) experiments. The rats were placed supine in a 13C/1H
radiofrequency volume coil, and either a 13C circular receive
surface coil or a 13C 4-channel receive array coil was placed over
the heart (all coils from RAPID Biomedical GmbH, Germany).
The volume coil had an inner diameter of 72 mm. The surface
coil had a diameter of 20 mm, and it was sensitive to a depth of
15 mm into the animal. The array coil consisted of 4 long
elements of length 42.5 mm, each element parallel to each other
covering the entire chest wall, and was sensitive to a depth of
20 mm. The coil sensitivity profiles of the surface coil and
the array coil in the transversal image plane are compared in
Figure 1, A and B. B0 shimming was performed, and anatomical
long-axis proton MR images were acquired for spatial localiza-
tion of the heart using a cardiac- and respiratory-gated cine
pulse sequence (repetition time [TR]  195 milliseconds; echo
time [TE]  3 milliseconds; field of view  60  120 mm2;
section thickness 2 mm; matrix size 128 256, number of
cardiac phases 8). The position of the coils was verified by an
external marker (oil pellet) placed on the top of the surface coil.
On the array coil, the oil pellet was placed on one side of the
coil and the animal was carefully placed so that the most
sensitive part of the coil was closest to the heart.
Hyperpolarized 13C MRI
Via the tail vein catheter, 1.0 mL of isotonic hyperpolarized
[1-13C]pyruvate solution was injected over 7–10 seconds; 7 s
after the end of injection, an ECG and respiratory-gated section-
selective chemical shift imaging sequence was started (section
thickness 5 mm, flip angle 10°, circular spiral k-space 12
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12 trajectory matrix, TR  69 milliseconds, TE  1.86 millisec-
onds, field of view 25 25 mm2). The chemical shift imaging
sequence was acquired from the same long-axis section through
the heart as the one used for the proton cine imaging.
Data Analysis
The [1-13C]pyruvate, [1-13C]lactate, [1-13C]alanine, and [13C]bi-
carbonate signals were quantified and mapped using in-house
written MATLAB program (The MathWorks, Natick, MA). [1-
13C]Pyruvate hydrate was also detected in the 13C spectrum, but
because it is not a direct metabolic product of pyruvate, it was
not included in the quantification. The postprocessing quantifi-
cation included apodization and zero-filling of the spatial di-
mensions to a matrix size of 32  32. The data were quantified
in magnitude mode. Spectral analysis was performed by simple
integration at predefined frequency offsets of the metabolites
relative to the frequency of the pyruvate peak. The chemical
shift imaging data were presented as metabolic maps, which
were registered to the corresponding first cardiac-phase cine
image (proton MRI).
The effect of ischemia on the cardiac metabolism was quan-
tified and illustrated using a region of interest analysis using the
bullseye analogy (14). The myocardium was divided in 4 re-
gions: apex (ischemic area in animals with lesion), anterior wall
(close to the coil), posterior wall (remote from the coil), and
left ventricular lumen (Figure 2). Hyperpolarized [1-13C]alanine,
[1-13C]lactate, and [13C]bicarbonate measured in all 4 regions
and normalized to (divided by) the [1-13C]pyruvate value for the
corresponding compartment, were used for comparison between
healthy (preischemia) and diseased (postischemia) hearts.
Late Enhancement MRI
In 7 of the rats, the infarct area was also verified by comparing
the metabolic maps visually with proton late Gd enhancement
images. ECG-gated inversion recovery gradient-echo MR im-
ages were obtained 10–20 minutes after the injection of 0.3
mmol/kg Gd-based contrast agent (Dotarem, Guerbet). The in-
version time was adjusted individually for each rat (350–500
milliseconds) to obtain the best contrast between the Gd-en-
hanced tissue and the surrounding healthy tissue (TR  600
milliseconds; TE  10 milliseconds; field of view  60  120
mm2; section thickness  2 mm; matrix size  192  512).
Statistics
A 2-way repeated ANOVA was performed to assess the differ-
ences between pre- and postischemic areas, and multiple com-
parisons were performed using Bonferroni post hoc correction.
Myocardial damage marker troponin I was assessed by a paired
t test assuming equal standard deviation, between baseline and
1 hour in the ischemia group (owing to unequal distribution of
data points and insufficient sham animals). Normality was as-
Figure 1. Coil profiles. Sensitivity profiles of the
circular surface receive coil and the 4-channel
array receive coil are compared in the axial im-
age plane. The sensitivity was measured using a
spherical phantom containing nonthermal polar-
ized [1-13C]pyruvate. The signals are normalized
to their maximum (100%). The coil sensitivity into
the animal (from coil surface to the heart) (A) and
the sensitivity length (along the coils in the axial
image plane, in a distance from the coil where
heart is assumed to be located) (B).
Figure 2. Illustration of region of interest and coil
placement. Schematic of the different regions used
for the regions of interest analysis in a long-axis
section through the myocardium: apex, anterior
wall, posterior wall, and left ventricular lumen.
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sessed with quantile–quantile plots. A value of P  .05 was
considered statistically significant. Statistical analysis was per-
formed using GraphPad Prism (GraphPad Software, Inc., La
Jolla, CA).
RESULTS
Hyperpolarized 13C MRI of the Healthy Heart
(Preischemia)
Hyperpolarized signal from [1-13C]pyruvate, [1-13C]lactate, [1-
13C]alanine, and [13C]bicarbonate was detected in the hearts of
all animals before ischemia. As expected, signal from [1-13C]py-
ruvate was primarily detected from blood inside the ventricle
(Figure 3, column 1). Signals from [1-13C]lactate, [1-13C]alanine,
and [13C]bicarbonate were confined to the myocardium (Figure 3,
columns 2–4). Because of the coil sensitivity profile, signals
were primarily visual in the anterior wall of the myocardium
closest to the coil. In some cases, lactate signal was observed
in the injured chest wall and in the blood inside the ventricle,
presumably because of the operative procedure (Figure 3,
column 2).
Effects of Ischemia
From the metabolic maps, we can observe that [1-13C]pyruvate
almost exclusively is seen in the ventricle and [1-13C]lactate is
seen both in the ventricle and the myocardium, whereas the
[1-13C]alanine and [1-13C]bicarbonate are seen exclusively in
the myocardium.
Apparent changes are seen in the raw lactate, alanine, and
bicarbonate images before and after ischemia (Figure 3, columns
2–4). No apparent differences are observed in the pyruvate
images (Figure 3, column 1). A decrease in the [1-13C]alanine
signal is observed in the ischemic region (distal, apex region) of
the anterior wall after ischemia compared with before ischemia
(Figure 3, column 3). An overall lower [1-13C]bicarbonate signal
is observed after ischemia. A statistical significant effect of
ischemia was observed in all the metabolite-to-pyruvate ratios
when comparing the interaction between time (before and after
ischemia) and intraregional differences (regions of interest). The
multiple comparison test showed a statistical significant differ-
ence between before and after ischemia, specifically in the apex
for [1-13C]alanine:[1-13C]pyruvate (P  .0001); [1-13C]lactate:
Figure 3. Hyperpolarized 13C metabolic images. Representative metabolic images of cardiac metabolism before isch-
emia (healthy heart, upper row) and after ischemia (30 minutes of ischemia followed by 2 hours of reperfusion, lower
row) for pyruvate, lactate, alanine, and bicarbonate (field of view  25  25 mm2, section thickness  5 mm, flip
angle  10°). The last column to the right shows the proton magnetic resonance imaging (MRI) of the heart: upper row,
before ischemic without enhancement; lower row, after ischemia with late enhancement image. In the late enhancement
image, enhanced signal can be observed in the distal ischemic region of the anterior myocardial wall (red arrow) and
in the tissue of the anterior chest wall.
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[1-13C]pyruvate (P  .0001); and the [1-13C]bicarbonate:[1-
13C]pyruvate (P  .002) (Figure 4A–C). Comparing the individ-
ual metabolites against each other is interesting because it could
indicate a shift from one metabolic pathway to another. How-
ever, no effect of ischemia could be observed in the [1-13C]ala-
nine:[1-13C]bicarbonate, [1-13C]lactate:[1-13C]alanine, or the
[1-13C]lactate:[1-13C]bicarbonate signals (Figure 4D–F).
Severity of Ischemia
Elevated signal in the late-enhancement images corresponded to
the area, which showed reduced 13C signal in the [1-13C]alanine
maps (Figure 3, column 5). The troponin I blood level peaked 1
hour after reperfusion (41.0  13.2 ng/mL, mean  standard
deviation, P  .0002) and remained elevated 2–3 hours after
reperfusion (Figure 5). In the 2 sham-operated rats, the 1-hour
value was in the normal range, 0.13 and 0.93 ng/mL. Further, as
mentioned in the Methods, ischemia was verified visually by
observing bleaching and blue coloring of the myocardium distal
to the ligature, and reperfusion was confirmed by a change in
color of the myocardium from blue to red.
DISCUSSION
Main Finding
The present study shows how hyperpolarized MRI can be used to
image regional metabolic changes in the in vivo rat heart fol-
lowing 30 minutes of ischemia. The observed decrease in [1-
13C]alanine, [1-13C]bicarbonate, and [1-13C]lactate signal in the
reperfused ischemic area likely reflects an overall depression of
Figure 4. Metabolic effect of
ischemia. Metabolic ratios in the
4 regions of interest. Left:
[1-13C]alanine:[1-13C]pyruvate (A),
[1-13C]lactate:[1-13C]pyruvate (B),
and [13C]bicarbonate:
[1-13C]pyruvate (C). Right:
[1-13C]alanine:[13C]bicarbonate
(D), [1-13C]lactate:[1-13C]alanine
(E), and [1-13C]lactate:[13C]bicar-
bonate (F). Significant differences
are indicated with an asterisk.
Mean and Standard Error of Mean
are presented in the figure.
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the cellular metabolism following 30 minutes of severe ischemia
and cell damage due to low supply of oxygen and nutrients to
the area. The metabolic maps show that changes in [1-13C]ala-
nine signal are a good marker for regional cellular damage
because the signal is well confined to the myocardium. There is
less disturbing contribution of [1-13C]alanine from the blood or
surrounding tissue, which can be the case for [1-13C]lactate,
which is produced in the injured tissue and transported out of
the cells into the blood stream. Lactate dehydrogenase has pre-
viously been used as a serum biomarker of myocardial infarc-
tion in the clinic, so enzyme leak may also contribute to the
reduced regional lactate and alanine signal (15). The severity of
the ischemic insult is supported by observed increase in blood
levels of troponin I, which is released to the blood because of
myocardial damage (16), as well as the late enhanced Gd signal
observed specifically in the ischemic region.
Our results support the recent findings by Oh-Ici, et al. (11).
In this study ischemia was induced by a closed chest technique
in rats. The LAD was occluded for 15 minutes and the [1-
13C]pyruvate metabolism evaluated after 3 minutes, 30 minutes,
1 hour and 1 week respectively. In the current study, we used
an open-chest model, and the effect of 30 minutes of ischemia
was evaluated 2 hours after reperfusion. Interestingly the
study by Oh-Ici, et al. shows an immediate change following
ischemia by a tendency toward a higher mean lactate:bicar-
bonate ratio from 3 minutes to 1 week later. Higher mean
lactate:bicarbonate ratio indicates alterations in the balance
between the aerobic and anaerobic glycolysis and thus devi-
ates from the findings in the present study. We speculate that
this discrepancy might originate from the difference in in-
duction and duration of ischemia (15 minutes vs 30 minutes
in our study), as a doubling time of a total acute ischemia rat
heart without collaterals is quite substantial and expected to
result in more severe metabolic changes. However, both stud-
ies show that hyperpolarized [1-13C]pyruvate is useful for the
evaluation of metabolic changes following cardiac ischemia
in rats.
Perfusion
As mentioned above, perfusion may be an interesting confound-
ing factor to the metabolic changes we observe. Low perfusion
to the ischemic area would result in lower/slower delivery of
[1-13C]pyruvate to the ischemic area, which would result in a
lower metabolic conversion of pyruvate to it metabolic products
as we observe. In the present study, reperfusion was ensured
visually in all rats before scanning. Rats in whom reperfusion
was not observed were immediately excluded from the study.
This is an advantage over the closed-chest model where
reperfusion not can be verified visually. However, to account
for minor hypoperfusion after reperfusion, the signal from
[1-13C]alanine, [1-13C]lactate, and [13C]bicarbonate was nor-
malized to the [1-13C]pyruvate signal. A reduced blood flow would
decrease the supply of oxygen and inhibit cellular oxygen-
dependent metabolism (bicarbonate reduction), whereas this
metabolic shift is believed to increase the lactate conversion
(Pasteur effect), and thus, the maintained balance between the
anaerobic and the aerobic pathways (lactate-to-bicarbonate)
suggests that the origin of the metabolic alterations is likely
stemming from a reduced nutrient uptake in the apex region
than from an oxygen-dependent altered metabolic conversion.
Bicarbonate
The overall low [13C]bicarbonate signal postischemia could be a
consequence of a general, low cardiac pyruvate dehydrogenase
activity in the rat heart because of a metabolism shift toward the
use of free fatty acids for energy production (17) and/or reduced
anaerobic glucose metabolism. It is known that glucose and free
fatty acids compete as substrates for energy production in the
heart, and especially during fasting when fatty acid utilization
increases and glucose metabolism and pyruvate dehydrogenase
activity decreases (18, 19). The postischemic condition could
mimic a “fasted” situation because the rat has been anesthetized
for a long time before scanning. Alternatively, the overall low
[13C]bicarbonate signal may be caused by a reduced carbonic
anhydrase activity owing to, for example, ischemic stress that
would increase the clearance of the rapidly diffusing (13) CO2 by
the blood and result in a reduced [13C]bicarbonate signal assum-
ing that the end metabolic product is CO2 and not H2CO3 (20).
Acidosis and increased flow would only, to a minor degree,
reduce the [13C]bicarbonate signal. The glycolytic metabolism
might fluctuate because of fluctuations in the glucose metabo-
lism and thereby result in an unstable [13C]bicarbonate signal. A
way to avoid fluctuations and keep a constant high plasma
glucose levels could be to supply the animal with an oral glucose
load or a direct infusion of glucose during the MR acquisition,
which previously has shown to ensure a high myocardial glu-
cose metabolism and a resulting high hyperpolarized [13C]bicar-
bonate signal (10, 11, 21). Looking back, imaging of the sham-
operated rats could have been useful to further evaluate the
effects of anesthesia on the metabolic signals.
Coils
Two different coils were used, and data from both coils were
included in the present study. A sensitivity profile of both coils
is shown in Figure 1. The reason for using 2 coils was to evaluate
their sensitivity and ensure coverage of the heart. Coverage of
Figure 5. Troponin I measurements. Blood levels
of troponin I measured before ischemia (0 hour)
and 1, 2, and 3 hours after reperfusion in isch-
emic (n  7) and sham-operated rats (n  2).
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the entire heart in the anterior–posterior direction (from coil surface
into the animal) was not achieved by any of the coils. A strong
signal was detected from the anterior wall closest to the coils, but
low 13C signal was detected from the posterior myocardial wall
using both coils. Thus, signal differences were only assessed in the
anterior wall, from a long-axis section. The length of the array coil
elements is 42.5 mm in the head to tail direction, which is suffi-
ciently long to cover the anterior wall. Because central positioning
of the heart in the coil always was ensured, and because the heart
was scanned both before and after ischemia with the same coil, the
effects from coil sensitivity profiles on the evaluation from the
anterior wall are considered to be negligible.
Concluding Remarks
This study shows that regional metabolic changes following
severe myocardial ischemia can be imaged in the in vivo rat heart
by means of hyperpolarized [1-13C]pyruvate. Signal from both
[1-13C]pyruvate, [1-13C]lactate, [1-13C]alanine, and [13C]bicarbon-
ate could be detected before ischemia, and localized metabolic
images of the anterior part of the rat myocardium using a
surface coil, a 4-channel array coil, and a simple chemical shift
imaging sequence could be produced. The decrease in the [1-
13C]alanine and [1-13C]lactate signals in the ischemic region after
30 minutes of occlusion of the LAD coronary artery suggests that
the ischemic insult is severe, affecting not only the sensitive mito-
chondrial metabolism but also the cytosolic metabolism. It most
likely reflects an overall depression of the cellular metabolism due
to nutrient starvation, which is in agreement with the results of
previous cardiac studies in pigs by use of hyperpolarized [1-13C]py-
ruvate (3, 6, 10). The metabolic finding was supported by the
concomitant increase in the blood levels of troponin I and en-
hanced Gd signal using late enhancement MRI.
This study and previous studies using hyperpolarized 13C
MRI suggest that the technique has the potential to advance
basic knowledge and improve diagnosis and prognosis of car-
diac diseases. A successful translation of hyperpolarized 13C MRI
into the clinic will require an extensive understanding of the
biological systems examined, which can be exploited in animal
models such as the one presented here. The first hyperpolarized
[1-13C]pyruvate MRI of a human heart was recently performed
(22), proving the feasibility of the technique to acquire high
signal-to-noise ratio metabolic images in human hearts. How-
ever, further technical advancements, such as increased polar-
ization, coils with better sensitivity, and improved MR se-
quences to detect low 13C signals, are still needed. In this study,
[1-13C]pyruvate was used. In addition, other hyperpolarized
substrates may offer alternative ways to study cardiac metabo-
lism or specific chemical pathways affected by disease.
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